AI in drug development 1

AI-powered crystal structure prediction for drug development. Lavo Life Sciences is a VC-backed, early-stage startup developing software tools for drug development. They offer AI-accelerated crystal structure prediction of small molecule drugs, helping to de-risk pipelines, optimize solid-state formulations, and avoid late-stage surprises. Their web-based platform, Crystal Console, provides powerful computational tools for crystal structure analysis, virtual polymorph screening, and PXRD analysis.